Dosing of medications in morbidly obese patients in the intensive care unit setting.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 14625670.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To derive recommendations for the dosing of commonly used medications in the morbidly obese patient in the ICU. Articles were obtained through computerized searches involving MEDLINE. The bibliographies of retrieved publications and textbooks were reviewed for additional references. All studies involving the pharmacokinetics or pharmacodynamics of medications in obese subjects or patients. The emphasis was on studies involving morbidly obese patients but, in the absence of such data, investigations involving lesser forms of obesity were extracted. There is a paucity of data upon which to make recommendations for dosing commonly used medications in the morbidly obese patient in the ICU, although recommendations were provided based on the available information. There is clearly a need for more investigations involving dosing regimens of medications in the morbidly obese population. Until such studies are available, the clinician must try to derive the best dosing regimens for medications based on the limited pharmacokinetic data available for some agents and clinical judgement.
Medical subject headings
- Critical Care
- Drug Monitoring
- Obesity, Morbid